Characterization and evaluation of the Moraxella catarrhalis oligopeptide permease A as a mucosal vaccine antigen

Infection and Immunity

Volumn 79, Issue 2, 2011, Pages 846-857

  Yang, Min ^a   Johnson, Antoinette ^a   Murphy, Timothy F ^a,b,c  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; BACTERIAL VACCINE; CHOLERA TOXIN; EPITOPE; LIPOPROTEIN; RECOMBINANT OLIGOPEPTIDE PERMEASE PROTEIN A VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM MUTANT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE SEQUENCE; HUMAN; IMMUNOGENICITY; MORAXELLA CATARRHALIS; MORAXELLACEAE INFECTION; MOUSE; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPTICAL DENSITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; TREATMENT RESPONSE;

ADMINISTRATION, MUCOSAL; ANIMALS; BACTERIAL PROTEINS; BACTERIAL VACCINES; CLONING, MOLECULAR; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; LUNG DISEASES; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED BALB C; MORAXELLA (BRANHAMELLA) CATARRHALIS; MORAXELLACEAE INFECTIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 79251507595     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00314-10     Document Type: Article

References (60)

1. Acosta, M. B., R. C. Ferreira, G. Padilla, L. C. Ferreira, and S. O. Costa. 2000. Altered expression of oligopeptide-binding protein (OppA) and aminoglycoside resistance in laboratory and clinical Escherichia coli strains. J. Med. Microbiol. 49:409-413.
2. Adlowitz, D. G., T. Hiltke, A. J. Lesse, and T. F. Murphy. 2004. Identification and characterization of outer membrane proteins G1a and G1b of Moraxella catarrhalis. Vaccine 22:2533-2540.
3. Adlowitz, D. G., S. Sethi, P. Cullen, B. Adler, and T. F. Murphy. 2005. Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalis. Infect. Immun. 73:6601-6607.
4. Alloing, G., B. Martin, C. Granadel, and J. P. Claverys. 1998. Development of competence in Streptococcus pneumoniae: pheromone autoinduction and control of quorum sensing by the oligopeptide permease. Mol. Microbiol. 29:75-83.
5. Bakri, F., A. L. Brauer, S. Sethi, and T. F. Murphy. 2002. Systemic and mucosal antibody response to Moraxella catarrhalis following exacerbations of chronic obstructive pulmonary disease. J. Infect. Dis. 185:632-640.
6. Becker, P. D., et al. 2007. Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimental murine model. Infect. Immun. 75:1778-1784.
7. Borezee, E., E. Pellegrini, and P. Berche. 2000. OppA of Listeria monocytogenes, an oligopeptide-binding protein required for bacterial growth at low temperature and involved in intracellular survival. Infect. Immun. 68:7069-7077.
8. Burnie, J., et al. 2002. Identification of ABC transporters in vancomycinresistant Enterococcus faecium as potential targets for antibody therapy. FEMS Immunol. Med. Microbiol. 33:179-189.
9. Burnie, J. P., et al. 2000. Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections. Infect. Immun. 68:3200-3209.
10. Crother, T. R., et al. 2004. Temporal analysis of the antigenic composition of Borrelia burgdorferi during infection in rabbit skin. Infect. Immun. 72:5063-5072.
11. Cullen, P. A., M. Lo, D. M. Bulach, S. J. Cordwell, and B. Adler. 2003. Construction and evaluation of a plasmid vector for the expression of recombinant lipoproteins in Escherichia coli. Plasmid 49:18-29. (Pubitemid 36269166)
12. Cundell, D. R., B. J. Pearce, J. Sandros, A. M. Naughton, and H. R. Masure. 1995. Peptide permeases from Streptococcus pneumoniae affect adherence to eucaryotic cells. Infect. Immun. 63:2493-2498.
13. de Vries, S. P. 2010. Genome analysis of Moraxella catarrhalis strain RH4, a human respiratory tract pathogen. J. Bacteriol. 192:3574-3583.
14. Faden, H., Y. Harabuchi, and J. J. Hong. 1994. Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: relationship to otitis media. J. Infect. Dis. 169:1312-1317.
15. Forsgren, A., M. Brant, and K. Riesbeck. 2004. Immunization with the truncated adhesin Moraxella catarrhalis immunoglobulin D-binding protein (MID764-913) is protective against M. catarrhalis in a mouse model of pulmonary clearance. J. Infect. Dis. 190:352-355.
16. Garmory, H. S., and R. W. Titball. 2004. ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies. Infect. Immun. 72:6757-6763.
17. Groeneveld, K., et al. 1989. Antigenic drift of Haemophilus influenzae in patients with chronic obstructive pulmonary disease. Infect. Immun. 57: 3038-3044.
18. Gu, X.-X., et al. 1998. Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis. Infect. Immun. 66:1891-1897.
19. Johnson, M. A., W. L. Drew, and M. Roberts. 1981. Branhamella (Neisseria) catarrhalis: a lower respiratory tract pathogen. J. Clin. Microbiol. 13:1066-1069.
20. Kerr, A. R., et al. 2004. The Ami-AliA/AliB permease of Streptococcus pneumoniae is involved in nasopharyngeal colonization but not in invasive disease. Infect. Immun. 72:3902-3906.
21. Klein, J. O. 1994. Otitis media. Clin. Infect. Dis. 19:823-833.
22. Lazazzera, B. A., J. M. Solomon, and A. D. Grossman. 1997. An exported peptide functions intracellularly to contribute to cell density signaling in B. subtilis. Cell 89:917-925.
23. Lee, E. M., et al. 2004. Identification of oligopeptide permease (opp) gene cluster in Vibrio fluvialis and characterization of biofilm production by oppA knockout mutation. FEMS Microbiol. Lett. 240:21-30.
24. Liu, D. F., J. C. McMichael, and S. M. Baker. 2007. Moraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse model. Infect. Immun. 75:2818-2825.
25. Mannino, D. M. 2002. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 121:121S-126S.
26. Mannino, D. M., and A. S. Buist. 2007. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370:765-773.
27. Mawas, F., M. M. Ho, and M. J. Corbel. 2009. Current progress with Moraxella catarrhalis antigens as vaccine candidates. Expert Rev. Vaccines 8:77-90.
28. Meier, P. S., et al. 2006. Unveiling electrotransformation of Moraxella catarrhalis as a process of natural transformation. FEMS Microbiol. Lett. 262:72-76.
29. Menard, R., P. J. Sansonetti, and C. Parsot. 1993. Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells. J. Bacteriol. 175:5899-5906.
30. Monnet, V. 2003. Bacterial oligopeptide-binding proteins. Cell. Mol. Life Sci. 60:2100-2114.
31. Monso, E., et al. 1995. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am. J. Respir. Crit. Care Med. 152:1316-1320.
32. Murphy, T. F. 2009. Vaccine development for Moraxella catarrhalis: rationale, approaches and challenges. Expert Rev. Vaccines 8:655-658.
33. Murphy, T. F., A. L. Brauer, B. J. Grant, and S. Sethi. 2005. Moraxella catarrhalis in chronic obstructive pulmonary disease. Burden of disease and immune response. Am. J. Respir. Crit. Care Med. 172:195-199.
34. Murphy, T. F., and G. I. Parameswaran. 2009. Moraxella catarrhalis, a human respiratory tract pathogen. Clin. Infect. Dis. 49:124-131.
35. Nowalk, A. J., R. D. Gilmore, Jr., and J. A. Carroll. 2006. Serologic proteome analysis of Borrelia burgdorferi membrane-associated proteins. Infect. Immun. 74:3864-3873.
36. Park, J. T., D. Raychaudhuri, H. Li, S. Normark, and D. Mengin-Lecreulx. 1998. MppA, a periplasmic binding protein essential for import of the bacterial cell wall peptide L-alanyl-gamma-D-glutamyl-meso-diaminopimelate. J. Bacteriol. 180:1215-1223.
37. Patel, J. A., et al. 1995. Bacteriologic failure of amoxicillin- clavulanate in treatment of acute otitis media caused by nontypeable Haemophilus influenzae. J. Pediatr. 126:799-806.
38. Pawelec, D., J. Jakubowska-Mroz, and E. K. Jagusztyn-Krynicka. 1998. Campylobacter jejuni 72Dz/92 cjaC gene coding 28 kDa immunopositive protein, a homologue of the solute-binding components of the ABC transport system. Lett. Appl. Microbiol. 26:69-76.
39. Pawelec, D., E. Rozynek, J. Popowski, and E. K. Jagusztyn-Krynicka. 1997. Cloning and characterization of a Campylobacter jejuni 72Dz/92 gene encoding a 30 kDa immunopositive protein, component of the ABC transport system; expression of the gene in avirulent Salmonella typhimurium. FEMS Immunol. Med. Microbiol. 19:137-150.
40. Petersen, C. 1992. Control of functional mRNA stability in bacteria: multiple mechanisms of nucleolytic and non-nucleolytic inactivation. Mol. Microbiol. 6:277-282.
41. Post, J. C., et al. 1995. Molecular analysis of bacterial pathogens in otitis media with effusion. JAMA 273:1598-1604.
42. Prymula, R., et al. 2006. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 367:740-748.
43. Ruckdeschel, E. A., A. L. Brauer, A. Johnson, and T. F. Murphy. 2009. Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis. Vaccine 27:7065-7072.
44. Ruckdeschel, E. A., C. Kirkham, A. J. Lesse, Z. Hu, and T. F. Murphy. 2008. Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection. Infect. Immun. 76:1599-1607.
45. Rudner, D. Z., J. R. LeDeaux, K. Ireton, and A. D. Grossman. 1991. The spo0K locus of Bacillus subtilis is homologous to the oligopeptide permease locus and is required for sporulation and competence. J. Bacteriol. 173:1388-1398.
46. Sable, S. B., I. Verma, and G. K. Khuller. 2005. Multicomponent antituberculous subunit vaccine based on immunodominant antigens of Mycobacterium tuberculosis. Vaccine 23:4175-4184.
47. Sarwar, J., A. A. Campagnari, C. Kirkham, and T. F. Murphy. 1992. Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis. Infect. Immun. 60:804-809.
48. Sethi, S., N. Evans, B. J. B. Grant, and T. F. Murphy. 2002. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med. 347:465-471.
49. Sethi, S., and T. F. Murphy. 2008. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N. Engl. J. Med. 359:2355-2365.
50. Shevchuk, N. A., et al. 2004. Construction of long DNA molecules using long PCR-based fusion of several fragments simultaneously. Nucleic Acids Res. 32:e19.
51. Tan, T. T., and K. Riesbeck. 2007. Current progress of adhesins as vaccine candidates for Moraxella catarrhalis. Expert Rev. Vaccines 6:949-956.
52. Tanabe, M., et al. 2006. The ABC transporter protein OppA provides protection against experimental Yersinia pestis infection. Infect. Immun. 74: 3687-3691.
53. Teele, D. W., J. D. Klein, and B. Rosner. 1989. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J. Infect. Dis. 160:83-94.
54. Verduin, C. M., C. Hol, A. Fleer, H. van Dijk, and A. van Belkum. 2002. Moraxella catarrhalis: from emerging to established pathogen. Clin. Microbiol. Rev. 15:125-144.
55. Vogel, L., et al. 1996. Immune selection for antigenic drift of major outer membrane protein P2 of Haemophilus influenzae during persistence in subcutaneous tissue cages in rabbits. Infect. Immun. 64:980-986.
56. Wang, C. H., et al. 2005. Effects of oligopeptide permease in group A streptococcal infection. Infect. Immun. 73:2881-2890.
57. Wang, W., et al. 2007. Metabolic analysis of Moraxella catarrhalis and the effect of selected in vitro growth conditions on global gene expression. Infect. Immun. 75:4959-4971.
58. Yadava, A., N. R. Suresh, S. A. Zaheer, G. P. Talwar, and R. Mukherjee. 1991. T-cell responses to fractionated antigens of Mycobacterium w, a candidate anti-leprosy vaccine, in leprosy patients. Scand. J. Immunol. 34:23-31.
59. Zalacain, R., et al. 1999. Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur. Respir. J. 13:343-348.
60. Zhang, G., K. Kiss, R. Seshadri, L. R. Hendrix, and J. E. Samuel. 2004. Identification and cloning of immunodominant antigens of Coxiella burnetii. Infect. Immun. 72:844-852.